Alzamend Neuro, Inc. (ALZN) Earnings
NASDAQ·Healthcare·Biotechnology
$1.27
-3.05%
Mkt Cap $6.84M
Awaiting Results
YesterdayTue, Jul 28, 2026
EPS Estimate
-$0.67
1 analysts
Revenue Estimate
$31.55M
Status
Awaiting actuals
Last quarter: missed by -9.43% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$6.84M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.85